$3.9 Billion Left for California's Stem Cell and Gene Therapy Program; What Will it Finance?

Rare disease advocates press their case in CIRM's current, sweeping priorities review. See schedule below for upcoming review meetings and topics.

Kim Nye, a rare disease advocate, addressed the CIRM board last week. Photo from CIRM TV video.

BURLINGAME, Calif. -- Bake sales, car washes, and lemonade stands don’t cut it in the big-bucks search for cures for often fatal rare diseases that affect an estimated nine million people in California. 

That was the message last week from three parents whose …